-
公开(公告)号：US11633449B2
公开(公告)日：2023-04-25
申请号：US17179054
申请日：2021-02-18
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyungsu Kim , Si Young Cho , A Young Kim , Wonseok Park , Yong Deog Hong
IPC: A61K36/82 , A61K31/353 , A61P35/00 , A61P15/12 , A23L33/105 , A23L2/52 , A23L33/00
Abstract: The present disclosure relates to a method for preventing, alleviating, improving or treating female hormone regulation disorder or symptoms, which contains a green tea extract with contents of ingredients changed. Specifically, the method according to an aspect of the present disclosure includes a step of administering an effective amount of a green tea extract, which contains (−)-gallocatechin gallate (GCG) and (−)-epigallocatechin gallate (EGCG) at specific contents, to a subject in need thereof, and may exhibit an effect of preventing, alleviating, improving or treating female hormone regulation disorder or symptoms.
-
公开(公告)号：US11110145B2
公开(公告)日：2021-09-07
申请号：US16110371
申请日：2018-08-23
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyungsu Kim , Ayoung Kim , Juewon Kim , Si Young Cho , Yong-Deog Hong
IPC: A61K36/82 , A61K36/00 , A61P39/06 , A61K31/353
Abstract: Disclosed is to provide a composition which is derived from a natural product and exhibits an excellent effect of protecting cells from oxidative stress and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural product, thus are safe. It can prevent, ameliorate and treat oxidative stress and neuron damage. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
-
公开(公告)号：US20250051385A1
公开(公告)日：2025-02-13
申请号：US18785473
申请日：2024-07-26
Applicant: AMOREPACIFIC CORPORATION
Inventor： Chan Su RHA , Jaeyoung Ko , Si Young Cho , Jin Nam
Abstract: A novel kaempferol compound is disclosed. The novel kaempferol compound is obtained by enzymatically treating kaempferol saccharides extracted from Camellia oleifera seed cake, which is discarded after oil extraction from camellia seeds, and a skin protection composition containing the same that is safe for the human body. The enzyme-treated-kaempferol compound has an increased molecular weight as sugar is additionally linked to the precursor kaempferol saccharide, and can exhibit a skin protection effect.
-
公开(公告)号：US12178837B2
公开(公告)日：2024-12-31
申请号：US18520281
申请日：2023-11-27
Applicant: AMOREPACIFIC CORPORATION
Inventor： Juewon Kim , Si Young Cho , Hyungsu Kim , Wonseok Park , Joonho Choi , Dong Hyun Kim , Jaewon You , Miyoung Park
IPC: A61K36/82 , A23L33/105 , A61K8/97 , A61Q19/02 , A61Q19/08
Abstract: Disclosed is to provide a composition for skin-whitening or preventing or improving skin wrinkles, comprising a green tea extract which has modified amounts of ingredients. More specifically, the extract and composition according to one aspect of the present disclosure are derived from natural plants that cause less irritation to the skin and are eco-friendly, thus they are safe, and thereby the extract and composition can exhibit excellent effects of effectively inhibiting melanin production and tyrosinase activity and preventing or improving skin whitening, and can exhibit excellent effects of effectively inhibiting the expression of MMP-1 and preventing or improving skin wrinkles.
-
公开(公告)号：US11744865B2
公开(公告)日：2023-09-05
申请号：US17726970
申请日：2022-04-22
Applicant: AMOREPACIFIC CORPORATION
Inventor： Eunmi Kim , Juewon Kim , Si Young Cho , Mihee Ji
CPC classification number: A61K35/74 , A23L33/135 , A23L33/40 , A61P17/00 , A61Q19/02 , A61Q19/08 , C12N1/205 , A23V2002/00 , C12R2001/01
Abstract: A composition for inhibiting lipofuscin accumulation or removing lipofuscin is disclosed. A Chryseobacterium sp. strain, a lysate of the Chryseobacterium sp. strain, a culture of the Chryseobacterium sp. strain, or an extract of the lysate or culture is included in the composition. The composition provides an anti-aging effect by inhibiting lipofuscin accumulation or removing lipofuscin. The composition also provides an effect of preventing, ameliorating or treating the diseases caused by the lipofuscin accumulation, such as skin hyperpigmentation, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, myocardial infarction and age-related macular degeneration.
-
Patent Agency Ranking
公开(公告)号：US10882882B2
公开(公告)日：2021-01-05
申请号：US16340920
申请日：2017-10-12
Applicant: AMOREPACIFIC CORPORATION
Inventor： Yong-Deog Hong , Minsik Choi , Si Young Cho , Jeong-Kee Kim
IPC: C12P19/60 , C07H17/07 , A61K31/7048 , A61K36/82
Abstract: The present specification relates to a novel compound separated from post fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, the compound being capable of being widely used in post fermented tea-related industries and various fields in which the compound may be used.
-
公开(公告)号：US10799551B2
公开(公告)日：2020-10-13
申请号：US16110299
申请日：2018-08-23
Inventor： Hyungsu Kim , Ayoung Kim , Juewon Kim , Si Young Cho , Yong-Deog Hong , Seung Soo Chung , Suk Jin Ko , Ji Hyun Jeong , Ji Woong Ahn
IPC: A61K36/82 , A61P25/00 , A61K31/353
Abstract: Disclosed is to provide a composition derived from a natural material and which has an excellent effect of enhancing cognitive function and a method for preparing the same. The extract and composition according to one aspect of the present disclosure are derived from a natural material and thus are safe. It can prevent, ameliorate and treat cognitive decline. Therefore, it allows to improve the quality of life of the elderly population without concerns about side effects and promote development of the related industry.
-
公开(公告)号：US09084785B2
公开(公告)日：2015-07-21
申请号：US14147102
申请日：2014-01-03
Applicant: AMOREPACIFIC CORPORATION
Inventor： Si Young Cho , Ji Hae Lee , Il Hong Bae , Min Jeong Song , Hyeon Ju Yeo , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A01N65/00 , A61K36/481 , A61K36/00 , A61K36/185 , A61K36/282 , A61K36/355 , A61K36/44 , A61K36/488 , A61K36/537 , A61K36/54 , A61K36/67 , A61K36/70 , A61K36/73 , A61K36/752 , A61K36/815 , A61K36/882 , A61K36/9064 , A61K31/202 , A61K36/424 , A61K45/06
CPC classification number: A61K36/481 , A61K31/202 , A61K36/00 , A61K36/185 , A61K36/282 , A61K36/355 , A61K36/424 , A61K36/44 , A61K36/488 , A61K36/537 , A61K36/54 , A61K36/67 , A61K36/70 , A61K36/73 , A61K36/752 , A61K36/815 , A61K36/882 , A61K36/9064 , A61K45/06 , A61K2300/00
Abstract: The present invention provides a composition for accelerating a change in muscle type, increasing the amount of muscle, strengthening muscle, enhancing athletic abilities, reducing lipids, suppressing the accumulation of lipids, lowering blood sugar, controlling body weight or lowering body weight, containing a PPAR-δ promoter, an AMPK promoter and a PGC1-α promoter as an active ingredient.
Abstract translation: 本发明提供一种用于加速肌肉类型变化，增加肌肉量，增强肌肉，增强运动能力，减少脂质，抑制脂质积聚，降低血糖，控制体重或降低体重的组合物， PPAR-δ启动子，AMPK启动子和PGC1-α启动子作为活性成分。
-
公开(公告)号：US11096921B2
公开(公告)日：2021-08-24
申请号：US15160218
申请日：2016-05-20
Applicant: AMOREPACIFIC CORPORATION
Inventor： Byung Gyu Kim , Hyun Woo Jeong , Su Kyung Kim , Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A61K31/34 , A61K36/258 , A23L33/11 , A23L33/105 , A23L2/52
Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
-
公开(公告)号：US20150283110A1
公开(公告)日：2015-10-08
申请号：US14437802
申请日：2013-11-29
Applicant: AMOREPACIFIC CORPORATION
Inventor： Si Young Cho , Dae Bang Seo , Chan Woong Park , Wan Gi Kim , Sang Jun Lee
CPC classification number: A61K31/34 , A23L33/10 , A23V2002/00 , A61K31/05 , A61K31/36
Abstract: The present invention relates to a composition for preventing or treating heart disease, and more particularly, to a composition for preventing or treating heart disease, comprising (+)-syringaresinol. Specifically, (+)-syringaresinol as an active ingredient may exhibit excellent effect of preventing or improving heart disease by promoting SIRT1 expression and suppressing death of cardiomyocytes induced by reactive oxygen species. Accordingly, the composition according to the present disclosure may be used to prevent, improve or treat heart diseases including cardiovascular diseases.
Abstract translation: 本发明涉及用于预防或治疗心脏病的组合物，更具体地说，涉及包含（+） - 丁香胺的心脏病预防或治疗组合物。 具体来说，作为活性成分的（+） - 丁二烯醇可以通过促进SIRT1表达并抑制由活性氧诱导的心肌细胞死亡而表现出优异的预防或改善心脏病的效果。 因此，根据本公开的组合物可用于预防，改善或治疗包括心血管疾病的心脏病。
-
-
-
-
-
-
-
-
-
Search Results
19
records
(took 0.015 seconds)
